|Year : 2020 | Volume
| Issue : 1 | Page : 24-29
Genetic characterization of a patient with Cornelia de Lange syndrome with a novel NIPBL missense mutation
Dalia F Hussen1, Saida A Hammad1, Ghada A Otaify2, Alaaeldin G Fayez3, Khaled M Refaat1, Aya Elaidy2, Mona S Aglan2, Samia A Temtamy2
1 Department of Human Cytogenetics, Human Genetics and Genome Research Division, Center of Excellence for Human Genetics, National Research Centre, Cairo, Egypt
2 Department of Clinical Genetics, Human Genetics and Genome Research Division, Center of Excellence for Human Genetics, National Research Centre, Cairo, Egypt
3 Department of Molecular Genetics and Enzymology, Human Genetics and Genome Research Division, Center of Excellence for Human Genetics, National Research Centre, Cairo, Egypt
|Date of Submission||18-Aug-2020|
|Date of Decision||05-Oct-2020|
|Date of Acceptance||15-Oct-2020|
|Date of Web Publication||31-Dec-2020|
Dalia F Hussen
Department of Human Cytogenetics, Human Genetics and Genome Research Division, National Research Centre, 33 El Buhouth Street, El-Dokki, Cairo 12622
Khaled M Refaat
Source of Support: None, Conflict of Interest: None
Cornelia de Lange syndrome (CdLS) is a rare clinically and genetically heterogeneous disease. Cardinal phenotypic manifestations include specific dysmorphic facial features, growth retardation, intellectual disability, and upper limb anomalies. Mutations in five genes including NIPBL, SMC1A, SMC3, RAD21, and HDAC8 are known to be responsible for the syndrome, with the NIPBL gene mutation being the most prevalent (~80%). This study aimed to report the clinical, cytogenetic, and molecular characterization of a patient with CdLS with a heterozygous novel exonic missense mutation of the NIPBL gene.
Patients and methods
We have studied a male patient of 9 years and 4 months of age who presented with features suggestive of CdLS. Thorough clinical examination, conventional cytogenetic analysis, and molecular study using direct Sanger sequencing were performed.
Clinical examination favored the diagnosis of CdLS. Conventional cytogenetic analysis revealed a normal 46, XY karyotype, with no evidence of premature sister chromatid separation. Molecular study showed a heterozygous novel exonic missense variant c. 2469G>T; p. (R657I) of the NIPBL gene.
A novel heterozygous exonic missense variant c. 2469G>T; p. (R657I) of the NIPBL gene was confirmed in our patient with CdLS. The phenotypic severity is probably correlated with the plausible effect of NIPBL gene mutation on the protein product rather than the variant type. The adverse effect of NIPBL gene mutation on the cohesion process mediated by cohesin complex is controversial.
Keywords: cohesion, Cornelia de Lange syndrome, craniofacial dysmorphism, NIPBL gene, premature sister, premature sister chromatid separation (pscs)
|How to cite this article:|
Hussen DF, Hammad SA, Otaify GA, Fayez AG, Refaat KM, Elaidy A, Aglan MS, Temtamy SA. Genetic characterization of a patient with Cornelia de Lange syndrome with a novel NIPBL missense mutation. Middle East J Med Genet 2020;9:24-9
|How to cite this URL:|
Hussen DF, Hammad SA, Otaify GA, Fayez AG, Refaat KM, Elaidy A, Aglan MS, Temtamy SA. Genetic characterization of a patient with Cornelia de Lange syndrome with a novel NIPBL missense mutation. Middle East J Med Genet [serial online] 2020 [cited 2021 Jan 22];9:24-9. Available from: http://www.mxe.eg.net/text.asp?2020/9/1/24/305865
| Introduction|| |
Cohesin is a complex of multiple proteins contributing in various DNA-related processes including sister chromatid cohesion and chromosomal segregation during mitosis (Gelot et al., 2016; Teresa-Rodrigo et al., 2016). Mutations in either the cohesin complex subunits or cofactors are responsible for a syndromic category termed cohesinopathies (Barbero, 2013).
Cornelia de Lange syndrome (CdLs) (MIM; #122470, #300590, #610759, #614701, and #300882) is the most frequent cohesinopathy (Piché et al., 2019), with an estimated prevalence of 1:10 000 live births (Cucco and Musio, 2016).
The condition is characterized clinically by distinctive craniofacial features including microcephaly, synophrys, arched eyebrows, flat nasal bridge, anteverted nares, long smooth philtrum, thin lips, micrognathia, and hirsutism. Growth retardation, intellectual disability, and upper limb anomalies are also cardinal features of this syndrome. Other manifestations, comprising gastroesophageal reflux, congenital heart diseases, and genitourinary problems, are also prevalent among patients with CdLs. (De Lange, 1933; Temtamy and Shoukry, 1975; Jackson et al., 1993; El-Ruby and Temtamy, 1997; Kline et al., 2007; Boyle et al., 2015; Dowsett et al., 2019).
Mutations in five genes encoding subunits of the cohesin complex [SMC1A (MIM*300040), SMC3 (MIM*606062), and RAD21 (MIM*606462)] and regulatory cofactors [NIPBL (MIM*608667) and HDAC8 (MIM*300269)] are known to be accountable for the emergence of CdLs (Krantz et al., 2004; Musio et al., 2006; Deardorff et al., 2012; Kaiser et al., 2014). Most molecularly diagnosed patients attain NIPBL gene mutation, which represent ∼80% (Kaiser et al., 2014; Boyle et al., 2015).
NIPBL (nipped-B-like) gene is located on chromosome 5p13.2. It consists of 47 exons encoding a component of the cohesin complex and acts as a cohesion loader, which enables loading of cohesin ring onto chromatin (Deardorff et al., 2012; Avagliano et al., 2020).
Heterozygous variants in the NIPBL gene mostly causes CdLS1 (MIM#122470) (Musio et al., 2006; Rohatgi et al., 2010), which is inherited in an autosomal dominant pattern (Russell et al., 2001; McConnell et al., 2003).
Herein, we report the clinical, cytogenetic, and molecular characterization of a patient with CdLS with a heterozygous novel exonic missense variant c. 2469G>T; p. (R657I) of the NIPBL gene. Direct Sanger sequencing has been done for the coding hot spot exons [2, 3, 7, 9 (A, B) 10 (A-F), 22, 35, 42, and 43] according to registered NIPBL variants in OMIM database (Online Mendelian Inheritance in Man, ▪)
| Clinical Report|| |
A male patient of 9 years and 4 months of age, presented to the General Genetics Clinic, National Research Centre, Cairo, Egypt, with dysmorphic features, short stature, and failure to thrive. He was the third child of nonconsanguineous parents, with older twin male siblings, one of them had hypospadias and a younger normal male [Figure 1]a. Pregnancy history was uneventful, and he was delivered at term via normal vaginal delivery. At birth, the age of his mother and father was 26 and 33 years old, respectively. The infant's birth weight was normal, and the clinical examination revealed hypospadias. Cystourethrogram showed hypospadias with narrow distal urethral opening, which was surgically corrected at the age of 2 years. He had normal motor milestones of development but showed delayed speech. At the time of presentation, the patient showed characteristic craniofacial features that were highly suggestive of CdLS, including microcephaly, low anterior and posterior hair lines, arched eyebrows, synophrys, long eyelashes, low-set posteriorly rotated ears, short broad nose, anteverted nares, long flat philtrum, thin lips, down-turned corners of the mouth, and short neck [Figure 1]b and [Figure 1]c. Upper limb examination showed bilateral clinodactyly of the little finger, limited elbow extension, dropped shoulders, and winging of scapulae. Lower extremities were normal, and examination of the trunk revealed loss of subcutaneous fat and wrinkled skin, and hirsutism over the back. Cardiac, respiratory, abdominal, and neurological examinations were normal. Genital examination showed a bilaterally palpable gonad, normal penile length of 5 cm, and surgically corrected urethral opening at the penile tip. Anthropometric measurements revealed short stature (−3.8 SD), microcephaly (−2.9 SD), and normal weight (−1.34 SD). Radiography for the left hand and wrist was performed to assess bone age using Greulich and Pyle method and showed a delayed bone age (6 years). Abdominopelvic ultrasound revealed ectopic pelvic right kidney. Echocardiogram was normal. intelligence quotient assessment using Wechsler test was 57, consistent with mild intellectual disability.
|Figure 1: The pedigree and dysmorphic features of the studied case. (a) Family pedigree with negative consanguinity, the affected proband, and older brother with hypospadias. (b) Face showing synophrys, arched eyebrows, long eyelashes, broad nose with anteverted nares, long smooth philtrum, thin lips, and low-set ears. (c) Back of head showing low posterior hair line, short neck, and hirsutism over the back.|
Click here to view
The study was conducted according to the guidelines of the Medical Research Ethics Committee of the National Research Centre and an informed consent has been taken from the patient's guardians.
Conventional cytogenetic analysis was performed to detect any associated numerical or structural chromosomal aberrations as well as any evidence for premature sister chromatid separation (PSCS), using GTG banding technique (Verma and Babu, 1995). Approximately 50 metaphases have been analyzed, and cytogenetic nomenclature was described following the International System for Human Cytogenomic Nomenclature recommendations (ISCN, 2016). Karyotype revealed a normal 46, XY male karyotype, and PSCS has not been detected in any of the studied metaphases [Figure 2].
|Figure 2: Normal male karyotype (46,XY), with no sister chromatid separation|
Click here to view
The whole coding hot spot exon sequences of NIPBL gene, including exons 2, 3, 7, 9 [A, B], 10 (A-F), 22, 35, 42, and 43, were genotyped by direct Sanger sequencing. Sequencing was performed using the BigDye Terminator Cycle Sequencing kit (Perkin-Elmer) on the ABI3730XL sequencer in Macrogen Inc. (Seoul, South Korea) (Supplementary 1).
Direct Sanger sequencing of the screened hot spot sequence showed two distinct variants [Figure 3]a, [Figure 3]b and [Figure 4]:
|Figure 3: (a) Partial sequence chromatogram showing heterozygous variant [rs300059, A>T]. (b) Partial sequence chromatogram showing the corresponding wild type.|
Click here to view
|Figure 4: Partial sequence chromatogram displaying the exon 10 of NIPBL gene for the proband presented R657I variant [G>T substitution].|
Click here to view
- Heterozygous reported intronic variant GRCh37.p13 chr5; NC_000005.9: g. 37052821A>T. It was reported as variant of unknown clinical significance but is not reported in ClinVar. Prediction of its probable pathogenicity was done using MutationTaster; TFBS analysis was done with regulation spotter, SNPnexus tools; and Variant Effect Predictor failed to predict pathogenic effect, and so it is considered to be a polymorphism.
- Heterozygous novel exonic missense variant c. 2469G>T; p. (R657I). Prediction of its probable pathogenicity was carried out using NNSPLICE (Reese et al., 1997). Human Splicing Finder (Desmet et al., 2009) showed that this variant is predicted to create a new splicing enhancer region linked to SRp55 protein. Therefore, the R657I variant might produce abnormal spliced mRNA causing the related phenotype. Molecular testing has been requested for the parents and siblings, but unfortunately, they did not show up again.
| Discussion|| |
CdLS is a rare clinically and genetically heterogeneous disease with a wide range of manifestations and multiorgan involvement; however, the characteristic facial dysmorphism is crucial for making the diagnosis (Van Allen et al., 1993; Gillis et al., 2004; Rohatgi et al., 2010).
In this study, we have encountered a male patient of 9 years and 4 months of age, who presented with distinguished craniofacial features that were highly suggestive of CdLS.
Our patient also showed growth retardation in the form of short stature, microcephaly, and delayed bone age. Retarded growth is considered a cardinal manifestation in this syndrome, (Boog et al., 1999; Boyle et al., 2015). Kline et al. (2007) reported that patients with CdLS usually have prenatal as well as enduring postnatal growth retardation. However, our patient had a normal birth weight.
The patient of the current study showed normal motor developmental milestones; however, his speech was delayed. Previous reports concluded that speech and language are the most severely affected fields of development. Approximately 35 and 25% of the patients present with delayed and limited speech, respectively (Sarimski, 1997; Kline et al., 2007).
Intellectual disability is common finding, which has various presentations ranging from mild to severe impairment (Boyle et al., 2015). Assessment of our patient revealed an intelligence quotient of 57 and rated as having mild intellectual disability.
Skeletal abnormalities are prevailing among these patients with extremity involvement in almost all of them, where upper limb is more commonly affected than lower limb. Upper limb anomalies include fifth finger clinodactyly (74% of the patients), limited elbow extension, and dislocation of radial head (64% of the patients). Limb reduction defects have been also described ranging from oligodactyly, ulnar deficiency to absent forearm (Jackson et al., 1993; Kline et al., 2007). The patient of the current study showed bilateral clinodactyly of little finger, limited elbow extension, dropped shoulders, and winging of scapulae, without any affection of lower extremities.
Renal malformations and urinary tract anomalies are frequent, reaching 40%. Approximately 57% of male patients usually experience hypoplastic genitalia and/or cryptorchidism (Borck et al., 2006; Minor et al., 2013). This was consistent with the findings in our patient, who showed ectopic right kidney and hypospadias with a narrow distal urethral opening that was surgically corrected at the age of 2 years.
Although patients with CdLS have numerous phenotypic features in common, patients' presentations usually vary from mild to severe, and detection of the causative gene mutation can give a clue for the genotype-phenotype correlation (Mannini et al., 2013).
Prevalence of NIPBL gene mutation among patients diagnosed by molecular techniques is estimated to be ~ 80% (Kaiser et al., 2014; Boyle et al., 2015) and is inherited in an autosomal dominant pattern (Russell et al., 2001; McConnell et al., 2003).
Various studies on human embryonic tissue showed expression of NIPBL gene in hand bones as well as the ulnar primordial cartilage. Subsequently, expression of this gene in the craniofacial tissue and spinal column was unveiled, which could rationalize the CdLS phenotype in correspondence to NIPBL gene mutation (Barbero, 2013; Zuin et al., 2014).
As open reading frame of NIPBL gene starts in exon 2, and continues to exon 47 (Tonkin et al., 2004), our study included hot mutant spot exons and detected a heterozygous reported intronic variant GRCh37.p13 chr5; NC_000005.9: g. 37052821A>T and identified a heterozygous novel exonic missense variant c. 2469G>T; p. (R657I).
Nucleotide alterations of NIPBL gene can cause changes in mRNA sequence transcripts and NIPBL protein structure and function. RNA sequencing approach could detect abnormal splicing and pathogenic variants among cases suspected to have CdLS (Krawczynska et al., 2019; Rentas et al., 2020). In correspondence to these conclusions and according to Human Splicing Finder (Desmet et al., 2009), pathogenicity of the novel p. (R657I) in our patient possibly resulted via producing abnormal spliced mRNA owing to creation of a new exonic splicing enhancer region linked to SRp55 protein.
The genotype reports of CdLS detected several variants including splice site, frameshift, small in frame deletion, and missense variants (Gillis et al., 2004; Oliveira et al., 2010; Park et al., 2010; Wang et al., 2017).
Splice site, frameshift, and nonsense variants are usually associated with a moderate to severe form of the syndrome. Phenotypic presentation usually includes severe dysmorphic facial features, moderate to severe developmental delay and growth retardation, moderate to profound intellectual disability, major organs anomalies, as well as limb involvement (Gillis et al., 2004; Boyle et al., 2015). Missense variants are generally associated with the milder phenotype, as it is usually characterized by mild intellectual disability, less severe developmental and growth affection, absent major organ anomaly, in addition to intact extremities (Mannini et al., 2013; Krawczynska et al., 2019).
Regarding our patient, apart from ectopic pelvic kidney, the presented phenotype is correlated with the mild phenotype previously described with the missense variant [Table 1]. Boyle et al. (2015) reported that phenotypic severity could be adjusted by other factors rather than the variant type, including loss of specific and larger coding sequences in NIPBL gene that affect critical domains of the protein as well as other genetic and environmental modifying factors. Moreover, point mutations at consensus 'cis' sequences that determine exon-intron boundaries or at other splicing regulatory sequences can lead to formation of an aberrant transcript and may result in faulty intron removal leading to alterations of the open reading frame (Anna and Monika 2018). These assumptions could justify the increased severity of phenotypic presentation in our patient despite having missense variant.
|Table 1: Phenotypic manifestations of our patient compared to common features of patients with missense variants of NIPBL gene as reported by Boyle et al. (2015)|
Click here to view
At the chromosomal level, NIPBL gene is required for loading of cohesin complex on chromatin during S-phase, G1, and G2 (Kajii and Ikeuchi, 2004; Deardorff et al., 2012). Cohesin by its turn is involved in chromatid cohesion and precise distribution of chromosomes during cell division (Peters et al., 2008; Jeppsson et al., 2014; De Gabory et al., 2018).
NIPBL gene is the human homolog of the Drosophila Nipped-B gene, which has been detected to be fundamental for sister chromatid cohesion during mitosis. This raised the suggestion that mutation of NIPBL gene in human could have a role in defective cohesion, and this defect will consequently lead to PSCS (Rollins et al., 2004).
Kaur et al. (2005) studied 90 patients with CdLS and 90 controls. They recognized a statistically significant increase in PSCS among the CdLS patients (41%) compared with the controls (9%). They concluded that perceiving PSCS could support the diagnosis in patients with CdLS when they are either tested negative for NIPBL gene mutation or molecular diagnosis is not undertaken.
However, Castronovo et al. (2009) in their study found no difference in the frequency of PSCS between the patients and controls and excluded its probable use as an additional diagnostic tool. In conformity to this study, we did not depict PSCS during performing cytogenetic analysis for our patient, and the karyotype showed a normal result (46, XY).
Subsequently, it was suggested that certain level of reduction in NIPBL transcription and dysregulation in the function of cohesin complex is required for the evolving of phenotypic abnormalities of CdLS owing to gene expression alteration; however, additional reduction is imperative for the affection of chromosomal segregation and the appearance of defective cohesion (Mannini et al., 2013).
Schwarzer et al. (2017) and Avagliano et al. (2020) accentuated that the biological mechanism of CdLS may not be directly associated with the disruption of sister chromatid cohesion but to the defective ability of the cohesin complex to regulate other cellular mechanisms including the expression of developmental genes.
Further researches are recommended to clarify the mechanisms of gene expression performed by the cohesin complex and how its dysfunction could contribute in the emerging of CdLS.
| Conclusion|| |
In this study, we report a patient with CdLS with heterozygous novel exonic missense variant c. 2469G>T; p. (R657I) of the NIPBL gene. The phenotypic severity is probably correlated with the plausible effect of NIPBL gene mutation on the protein product rather than the variant type. Genotypic–phenotypic correlation could not be maintained at the cytogenetic level as the role of NIPBL gene mutation on the sister chromatid cohesion mediated by cohesin complex is still debatable.
The authors acknowledge the Science and Technology Development Fund (STDF), Centre of Excellence for Human Genetics (project number: 5253) and the National Research Centre (NRC), Egypt (project no. 11010164) for funding this research.
Financial support and sponsorship
This work is funded by STDF project#5253 and NRC project#11010164.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Anna A, Monika G (2018). Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet 59
Avagliano L, Parenti I, Grazioli P, Di Fede E, Parodi C, Mariani M, et al
. (2020). Chromatinopathies: a focus on Cornelia de Lange syndrome. Clin Genet 97
Barbero JL (2013). Genetic basis of cohesinopathies. Appl Clin Genet 6: 15–23.
Boog G, Sagot F, Winer N, David A, Nomballais MF (1999). Brachmann–de Lange syndrome: a cause of early symmetric fetal growth delay. Eur J Obstet Gynecol Reprod Biol 85
Borck G, Zarhrate M, Cluzeau C, Bal E, Bonnefont JP, Munnich A, et al
. (2006). Father-to-daughter transmission of Cornelia de Lange syndrome caused by a mutation in the 5' untranslated region of the NIPBL Gene. Hum Mutat 27: 731–735.
Boyle M, Jespersgaard C, Brøndum-Nielsen K, Bisgaard AM, Tümer Z (2015). Cornelia de Lange syndrome. Clin Genet 88
Castronovo P, Gervasini C, Cereda A, Masciadri M, Milani D, Russo S, et al
. (2009). Premature chromatid separation is not a useful diagnostic marker for Cornelia de Lange syndrome. Chromosome Res 17
Cucco F, Musio A (2016) Genome stability: what we have learned from cohesinopathies. Am J Med Genet C Semin Med Genet 172
Deardorff MA, Wilde JJ, Albrecht M, Dickinson E, Tennstedt S, Braunholz D, et al
. (2012). RAD21 mutations cause a human cohesinopathy. Am J Hum Genet 90
De Gabory CL, Abou-Sleymane G, Stora S, Obeid M, Mikael D, Megarbane A (2018). Cornelia de Lange syndrome type 5: report of two new cases. Middle East J Med Genet 7
De Lange C (1933). Sur un type nouveau de degenerescence (typus Amstelodamensis). Arch Med Enfants 36
Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C (2009). Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37
: e67. 10.1093/nar/gkp215.
Dowsett L, Porras AR, Kruszka P, Davis B, Hu T, Honey E, et al
. (2019). Cornelia de Lange syndrome in diverse populations. Am J Med Genet A 179
El-Ruby M, Temtamy SA (1997).The Delange syndrome with bilateral hemimelia and normal karyotype. Egypt J Pediatr 14
Gelot C, Guirouilh-Barbat J, Le Guen T, Dardillac E, Chailleux C, Canitrot Y, Lopez BS (2016). The cohesin complex prevents the end joining of distant DNA double-strand ends. Mol Cell 61
Gillis LA, McCallum J, Kaur M, DeScipio C, Yaeger D, Mariani A, et al
. (2004). NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations. Am J Hum Genet 75
Jackson L, Kline AD, Barr M, Koch S (1993). de Lange syndrome: a clinical review of 310 individuals. Am J Med Genet 47
Jeppsson K, Kanno T, Shirahige K, Sjögren C (2014). The maintenance of chromosome structure: positioning and functioning of SMC complexes. Nat Rev Mol Cell Biol 15
Kaiser FJ, Ansari M, Braunholz D, Concepcion Gil-Rodriguez M, Decroos C, Wilde JJ, et al
. (2014). Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance. Hum Mol Genet 23
Kajii T, Ikeuchi T (2004). Premature chromatid separation (PCS) vs. premature centromere division (PCD). Am J Med Genet A 126
Kaur M, DeScipio C, McCallum J, Yaeger D, Devoto M, Jackson LG, et al
. (2005). Precocious sister chromatid separation (PSCS) in Cornelia de Lange syndrome. Am J Med Genet A 138
Kline AD, Krantz ID, Sommer A, Kliewer M, Jackson LG, FitzPatrick DR, et al
. (2007). Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A 143
Krantz ID, McCallum J, DeScipio C, Kaur M, Gillis LA, Yaeger D, et al
. (2004). Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet 36
Krawczynska N, Wierzba J, Jasiecki J, Wasag B (2019). Molecular characterization of two novel intronic variants of NIPBL gene detected in unrelated Cornelia de Lange syndrome patients. BMC Med Genet 20
Mannini L, Cucco F, Quarantotti V, Krantz ID, Musio A (2013). Mutation spectrum and genotype–phenotype correlation in Cornelia de Lange syndrome. Hum Mutat 34
Mcgowan-Jordan J, Simons A, Schmid M (2016). An International System for Human Cytogenomic Nomenclature (ISCN). Basel: S. Karger.
Minor A, Shinawi M, Hogue JS, Vineyard M, Hamlin DR, Tan C, et al
. (2013). Two novel RAD21 mutations in patients with mild Cornelia de Lange syndrome-like presentation and report of the first familial case. Gene 537
Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, Russo S, et al.
(2006). X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat Genet 38
Oliveira J, Dias C, Redeker E, Costa E, Silva J, Reis Lima M, et al.
(2010). Development of NIPBL locus-specific database using LOVD: from novel mutations to further genotype-phenotype correlations in Cornelia de Lange Syndrome. Hum Mutat 31
Online Mendelian Inheritance in Man.1966-2020. Baltimore: Johns Hopkins University. Available at: http://omim.org/
Park HD, Ki CS, Kim JW, Kim WT, Kim JK (2010). Clinical and genetic analysis of Korean patients with Cornelia de Lange syndrome: two novel NIPBL mutations. Ann Clin Lab Sci 40
Peters JM, Tedeschi A, Schmitz J (2008). The cohesin complex and its roles in chromosome biology. Genes Dev 22
Piché J, Van Vliet PP, Pucéat M, Andelfinger G (2019) The expanding phenotypes of cohesinopathies: one ring to rule them all!. Cell Cycle 18
Rentas S, Rathi KS, Kaur M, Raman P, Krantz ID, Sarmady M, et al
. (2020); Diagnosing cornelia de lange syndrome and related neurodevelopmental disorders using RNA sequencing. Genet Med 22
Reese MG, Eeckman FH, Kulp D, Haussler D (1997). Improved splice site detection in Genie. J Comput Biol 4
Rohatgi S, Clark D, Kline AD, Jackson LG, Pie J, Siu V, et al
. (2010). Facial diagnosis of mild and variant CdLS: insights from a dysmorphologist survey. Am J Med Genet A 152A
Rollins RA, Korom M, Aulner N, Martens A, Dorsett D (2004). Drosophila nipped-B protein supports sister chromatid cohesion and opposes the stromalin/Scc3 cohesion factor to facilitate long-range activation of the cut gene. Mol Cell Biol 24
Russell KL, Ming JE, Patel K, Jukofsky L, Magnusson M, Krantz ID (2001). Dominant paternal transmission of Cornelia de Lange syndrome: a new case and review of 25 previously reported familial recurrences. Am J Med Genet 104
Sarimski K (1997) Communication, social-emotional development and parenting stress in Cornelia de Lange syndrome. Journal of Intellectual Disability Research
Schwarzer W, Abdennur N, Goloborodko A, Pekowska A, Fudenberg G, Loe-Mie Y, et al
. (2017). Two independent modes of chromatin organization revealed by cohesin removal. Nature 551
Temtamy SA, Shoukry AS (1975). Cornelia de Lange syndrome in an Egyptian child. Birth Defects Orig Artic Ser 11
Teresa-Rodrigo ME, Eckhold J, Puisac B, Pozojevic J, Parenti I, Baquero-Montoya C, et al
. (2016). Identification and functional characterization of two intronic NIPBL mutations in two patients with Cornelia de Lange syndrome. Biomed Res Int 12
Tonkin ET, Wang TJ, Lisgo S, Bamshad MJ, Strachan T (2004). NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome. Nat Genet 36
Van Allen MI, Filippi G, Siegel-Bartelt J, Yong SL, McGillivray B, Zuker RM, et al
. (1993). Clinical variability within Brachmann-de Lange syndrome: a proposed classification system. Am J Med Genet 47
Verma RS, Babu A (1995). Human Chromosomes: A Manual of Basic Techniques
. New York, NY: McGraw-Hill.
Wang Y, Wang X, Mei Y, Peng W, Liu X, Liu Y, Feng Z (2017). Two novel NIPBL mutations in three Chinese neonates with Cornelia de Lange syndrome identified by disease-associated genome panel. Int J Clin Exp Med 10
Zuin J, Franke V, van IJcken WF, Van Der Sloot A, Krantz ID, van der Reijden MI, et al
. (2014). A cohesin-independent role for NIPBL at promoters provides insights in CdLS. PLoS Genet 10
[Figure 1], [Figure 2], [Figure 3], [Figure 4]